BlackRock Institutional Trust’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

BlackRock Institutional Trust’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$33M	Buy	306,890 +107,508	+54%	+$12.6M	﹤0.01%	1604
2016 Q3	$24.8M	Buy	199,382 +99,596	+100%	+$11.8M	﹤0.01%	1729
2016 Q2	$10.6M	Buy	+99,786	New	+$11.6M	﹤0.01%	2257
2016 Q1	–	Sell	-16,405	Closed	-$2.34M	–	3984
2015 Q4	$2.34M	Sell	16,405 -9,218	-36%	-$1.06M	﹤0.01%	3057
2015 Q3	$2.3M	Sell	25,623 -182,293	-88%	-$19.2M	﹤0.01%	3067
2015 Q2	$23.9M	Buy	207,916 +133,074	+178%	+$14M	﹤0.01%	1802
2015 Q1	$7.15M	Buy	74,842 +25,765	+52%	+$1.93M	﹤0.01%	2590
2014 Q4	$3.3M	Sell	49,077 -8,206	-14%	-$509K	﹤0.01%	2901
2014 Q3	$3.09M	Sell	57,283 -2,004	-3%	-$98.6K	﹤0.01%	2885
2014 Q2	$2.64M	Buy	59,287 +1,493	+3%	+$61K	﹤0.01%	3069
2014 Q1	$2.01M	Sell	57,794 -29,081	-33%	-$926K	﹤0.01%	3161
2013 Q4	$2.51M	Sell	86,875 -4,636	-5%	-$134K	﹤0.01%	3070
2013 Q3	$2.67M	Sell	91,511 -18,892	-17%	-$471K	﹤0.01%	2994
2013 Q2	$2.56M	Buy	+110,403	New	+$2.79M	﹤0.01%	2970

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock Institutional Trust's CBPO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its China Biologic Products Holdings, Inc. (CBPO) stake by 54% in Q4 2016, buying an estimated $12.6M and bringing the position to 306,890 shares worth $33M. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

BlackRock Institutional Trust first reported a position in CBPO in Q2 2013 and has held it in 14 quarters since. 143 funds tracked by Wall St. Rank hold CBPO as of Q4 2016.

BlackRock Institutional Trust held 306,890 shares of China Biologic Products Holdings, Inc. worth $33M as of Q4 2016.
BlackRock Institutional Trust bought 107,508 China Biologic Products Holdings, Inc. shares in Q4 2016, an estimated $12.6M.
China Biologic Products Holdings, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1604 holding.
BlackRock Institutional Trust first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and has held it in 14 quarters since.
143 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.